Clinical Care

Time saved with Alzheimer’s disease therapeutics

Challenges in diagnosing dementia in Asian countries

Neurological health and dementia in China after COVID lockdowns

Contextualizing the World-Wide FINGER trials in the real-world

Treating patients with hearing loss and cognitive impairment

Roadblocks to the use of blood-based biomarkers in clinical care

Blood-based biomarkers for treatment monitoring in Alzheimer’s disease

Recognizing and managing pain in the context of cognitive impairment

Behavioral changes and dementia risk

A single question dementia screening method

Impact of the COVID-19 pandemic on patients with dementia and PD and their caregivers in Peru

Voice-recognition based screening for MCI and dementia in older Chinese adults

Marked excessive mortality risk associated with new opioid use in older people with dementia

ALZ-NET: examining novel approved treatments in the real-world

Development of Appropriate Use Recommendations for lecanemab

Prospects for Alzheimer’s disease monitoring and treatment in 2023